The effects of cisapride on the topography of oesophageal peristalsis

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 875-882

  Staiano, A ^a   Clouse, R E ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Children's Annex   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; ESOPHAGUS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE CONTRACTION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PERISTALSIS; PRIORITY JOURNAL; SMOOTH MUSCLE; VOLUNTEER;

EID: 0029802471     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.94266000.x     Document Type: Article

References (26)

1. Biancani P, Behar J. Esophageal motor function. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of Gastroenterology, 2nd edn. Philadelphia, Pennsylvania: JB Lippincott Co., 1995: 158-80.
2. Crist JJ, Gidda JS, Goyal RK. Intramural mechanism of esophageal peristalsis: roles of cholinergic and noncholinergic nerves. Proc Natl Acad Sci USA 1984; 81: 3595-9.
3. Clouse RE, Staiano A. Topography of the esophageal peristaltic pressure wave. Am J Physiol (Gastrointest Liver Physiol) 1991: 261 (24): G677-84.
4. Clouse RE, Staiano A. Topography of normal and high-amplitude esophageal peristalsis. Am J Physiol (Gastrointest Liver Physiol) 1993; 265 (28): G1098-1107.
5. Reyntjens A. Rationale for the development of a novel gastrointestinal prokinetic, cisapride. Scand J Gastroenterol 1989; 24 (Suppl. 165): 1-6.
6. Clouse RE, Staiano A. Manometric patterns using esophageal body and lower sphincter characteristics: Findings in 1013 patients. Dig Dis Sci 1992; 37: 289-96.
7. Arndorfer RC, Stef JJ, Dodds WJ, Hogan WJ. Improved infusion system for intraluminal esophageal manometry. Gastroenterology 1975; 68: 437-43.
8. Meyer GW, Gerhardt DC, Castell DO. Human esophageal response to rapid swallowing: muscle refractory period of neural inhibition? Am J Physiol 1981; 241: G129-36.
9. Aliperti G, Clouse RE. Incomplete lower esophageal sphincter relaxation in subjects with peristalsis: prevalence and clinical outcome. Am J Gastroenterol 1991; 86: 609-14.
10. Keckler D. The Surfer for Windows User Guide. Golden, Colorado: Golden Software, 1994: 14.4-11.
11. Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47: 116-52.
12. Wiley JW. Effect of cisapride on cholinergic neurotransmission and isolated gastric smooth muscle cells. In: Heading RC, Wood JD, ed. Gastrointestinal Dysmotility: Focus on Cisapride. New York: Raven Press, 1992: 73-84.
13. Schuurkes J. Facilitation of acetylcholine release via serotonin receptors: effect of cisapride? In: Heading RC, Wood JD, ed. Gastrointestinal Dysmotility: Focus on Cisapride. New York: Raven Press, 1992: 107-15.
14. Schuurkes JAJ, Van Bergen PJE, Van Nueten JM. Cholinergic innervation of the feline oesophagus. Br J Pharmacol 1989;96 (Suppl.): 50P.
15. Bingham S, Andrews PLR. Gastrointestinal motility effects of cisapride mediated by nonadrenergic, noncholinergic nerves. In: Heading RC, Wood JD, ed. Gastrointestinal Dysmotility: Focus on Cisapride. New York: Raven Press, 1992: 93-106.
16. Anand N, Paterson WG. Role of nitric oxide in esophageal peristalsis. Am J Physiol (Gastrointest Liver Physiol) 1994; 266 (29): G123-31.
17. Dodds WJ, Dent J, Hogan WJ, Arndorfer RC. Effect of atropine on esophageal motor function in humans. Am J Physiol (Gastrointest Liver Physiol) 1981; 240 (3): G290-6.
18. Paterson WG, Hynna-Liepert TT, Selucky M. Comparison of imary and secondary esophageal peristalsis in humans: effect of atropine. Am J Physiol (Gastrointest Liver Physiol) 1991; 260 (23): G52-7.
19. Eriksen CA, Sutton D, Kennedy N, Cushieri A. Cisapride improves oesophageal transit in patients with dysphagia. Results of a randomised double-blind crossover trial. Gut 1987; 28:A 1377.
20. Horowitz M, Maddox A, Harding PE, et al. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 1987; 92: 1899-1907.
21. Cucchiara S, Staiano A, Boccieri A, et al. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Gut 1990; 31: 21-5.
22. Inauen W, Emde C, Wever B, et al. Effects of ranitidine and sapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Gut 1993; 34: 1025-31.
23. Rode H, Stunden RJ, Willar AJW, Cywes S. Esophageal pH assessment of gastroesophagela reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide. J Pediatr Surg 1987; 22: 931-4.
24. Ceccatelli P, Janssens J, Vantrappen G, Cucchiara S. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut 1988; 29: 631-5.
25. Corazziari E, Bontempo I, Anzini F. Effects of cisapride on distal esophageal motility in humans. Dig Dis Sci 1989; 34: 1600-5.
26. Gilbert RJ, Dodds WJ, Kahrilas PJ, Hogan WJ, Lipman S. Effect of cisapride, a new prokinetic agent, on esophageal motor function. Dig Dis Sci 1987; 32: 1331-6.